The drug discovery phase focuses on identifying a biological target and finding a "lead" compound that can modulate it.
Using panels of 50+ receptors and ion channels (e.g., the CEREP panel), pharmacologists screen promising compounds for unwanted interactions. The most infamous example: terfenadine (Seldane), an antihistamine that blocked hERG potassium channels in the heart, causing fatal arrhythmias. Today, hERG screening is mandatory early in discovery.
Pharmacology is the study of how drugs interact with biological systems. In the pharmaceutical industry, it serves as the scientific foundation for transforming a chemical or biological concept into a life-saving medicine. This article explores the essential role of pharmacology across the five main pillars of drug discovery and development: target identification, lead discovery, optimization, preclinical testing, and clinical trials. 1. The Foundation: Discovery Pharmacology
Here is how pharmacology powers every stage of the drug discovery and development pipeline. pharmacology in drug discovery and development
Pharmacology enabled the transformation of a short-lived gut hormone (GLP-1, half-life ~2 min) into a once-weekly drug. Through medicinal chemistry modifications (fatty acid acylation for albumin binding), pharmacologists extended half-life to ~7 days. PK/PD modeling then determined the right dosing regimen for glycemic control and, unexpectedly, profound weight loss—uncovering the drug’s action on CNS appetite centers.
Artificial intelligence and machine learning models can now predict the PK/PD properties of billions of virtual molecules before they are ever synthesized in a lab, radically shortening the discovery phase.
: Thousands of chemical compounds are tested against the target to find "hits" that show activity. The drug discovery phase focuses on identifying a
is the core scientific framework that transforms raw chemical compounds and biological molecules into safe, life-saving medicines. By mapping the exact interactions between a drug and the human body, pharmacology provides the essential data needed to validate therapeutic targets, optimize drug design, and establish safe dosing parameters for clinical trials.
Provide a deeper dive into
Pharmacology is the vital bridge in drug discovery and development, providing the scientific framework to understand how a potential medicine interacts with the body. By integrating the two core disciplines— pharmacokinetics (PK) pharmacodynamics (PD) Today, hERG screening is mandatory early in discovery
In this phase, the PK/PD loop is relentless:
The complexity of the drug discovery and development process is reflected in its staggering cost. While estimates vary based on methodology, the financial investment required to bring a new drug to market is immense. A 2025 report from Deloitte found that the average capitalized cost to develop a new drug had climbed to approximately . A significant portion of this cost is driven by high failure rates, particularly in expensive late-stage clinical trials, which can account for more than half of total development spending. It is in the challenging context of ever-increasing costs that innovations in pharmacology are most critically needed.
: Bind to the receptor and trigger a maximum biological response.
How the body eliminates the waste (mostly via the kidneys). 2. Early-Stage Discovery: Finding the Right Target
At the heart of pharmacological science lies the study of how drugs interact with the body. This is broadly divided into two core disciplines: and Pharmacokinetics (PK) . Pharmacodynamics: What the Drug Does to the Body